 Brian Russo
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shigella flexneri | 7 | 2021 | 12 | 3.780 |
Why?
| | Type III Secretion Systems | 5 | 2021 | 10 | 3.390 |
Why?
| | Antigens, Bacterial | 4 | 2020 | 131 | 2.480 |
Why?
| | Host-Pathogen Interactions | 7 | 2021 | 316 | 1.880 |
Why?
| | Francisella tularensis | 7 | 2019 | 16 | 1.680 |
Why?
| | Cell Membrane | 4 | 2021 | 771 | 1.550 |
Why?
| | Tularemia | 7 | 2019 | 12 | 1.450 |
Why?
| | Virulence | 7 | 2021 | 248 | 1.440 |
Why?
| | Dysentery, Bacillary | 3 | 2021 | 6 | 1.300 |
Why?
| | Bacterial Proteins | 8 | 2021 | 759 | 0.930 |
Why?
| | Bacterial Adhesion | 2 | 2019 | 81 | 0.800 |
Why?
| | Actins | 1 | 2021 | 370 | 0.800 |
Why?
| | Porins | 1 | 2019 | 14 | 0.790 |
Why?
| | Virulence Factors | 2 | 2016 | 132 | 0.700 |
Why?
| | Yersinia pseudotuberculosis | 1 | 2016 | 3 | 0.640 |
Why?
| | Vimentin | 1 | 2016 | 60 | 0.620 |
Why?
| | HeLa Cells | 5 | 2021 | 639 | 0.600 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 184 | 0.550 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 111 | 0.500 |
Why?
| | Protein Transport | 3 | 2019 | 456 | 0.480 |
Why?
| | Spermine | 1 | 2011 | 28 | 0.460 |
Why?
| | Cost of Illness | 1 | 2013 | 288 | 0.440 |
Why?
| | Protein Binding | 4 | 2019 | 2115 | 0.380 |
Why?
| | Transferases | 2 | 2021 | 31 | 0.370 |
Why?
| | Lung Diseases | 1 | 2013 | 750 | 0.320 |
Why?
| | Patient Acuity | 1 | 2022 | 26 | 0.240 |
Why?
| | Cross Reactions | 1 | 2021 | 157 | 0.230 |
Why?
| | Alveolar Epithelial Cells | 1 | 2022 | 86 | 0.220 |
Why?
| | Endothelium | 1 | 2022 | 134 | 0.220 |
Why?
| | Polymerization | 1 | 2021 | 120 | 0.220 |
Why?
| | Immunity, Humoral | 1 | 2021 | 93 | 0.220 |
Why?
| | Viremia | 1 | 2021 | 127 | 0.210 |
Why?
| | Glycosyltransferases | 1 | 2019 | 10 | 0.210 |
Why?
| | Signal Transduction | 2 | 2014 | 4923 | 0.210 |
Why?
| | Sequence Deletion | 2 | 2011 | 191 | 0.210 |
Why?
| | Mice | 6 | 2019 | 15641 | 0.200 |
Why?
| | Pulmonary Alveoli | 1 | 2022 | 407 | 0.190 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 5249 | 0.190 |
Why?
| | Cytokines | 4 | 2019 | 1981 | 0.180 |
Why?
| | Cells, Cultured | 2 | 2019 | 4429 | 0.160 |
Why?
| | Sheep | 1 | 2019 | 784 | 0.160 |
Why?
| | Keratin-18 | 1 | 2016 | 12 | 0.160 |
Why?
| | Animals | 9 | 2019 | 35394 | 0.160 |
Why?
| | Protein Conformation | 1 | 2019 | 974 | 0.160 |
Why?
| | ADP-Ribosylation Factors | 1 | 2015 | 16 | 0.150 |
Why?
| | LIM Domain Proteins | 1 | 2014 | 19 | 0.140 |
Why?
| | GTPase-Activating Proteins | 1 | 2015 | 73 | 0.140 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2015 | 57 | 0.140 |
Why?
| | Humans | 14 | 2022 | 113846 | 0.140 |
Why?
| | Amino Acid Oxidoreductases | 1 | 2013 | 22 | 0.140 |
Why?
| | Scleroderma, Systemic | 1 | 2014 | 89 | 0.140 |
Why?
| | Endocytosis | 1 | 2015 | 151 | 0.140 |
Why?
| | Multienzyme Complexes | 1 | 2013 | 74 | 0.130 |
Why?
| | Models, Molecular | 1 | 2019 | 1604 | 0.130 |
Why?
| | Cytoskeletal Proteins | 1 | 2014 | 165 | 0.130 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 144 | 0.130 |
Why?
| | Macrophages | 4 | 2019 | 1343 | 0.130 |
Why?
| | Protein Kinase C | 1 | 2014 | 354 | 0.120 |
Why?
| | Cell Death | 1 | 2013 | 348 | 0.110 |
Why?
| | Vaccines, Attenuated | 1 | 2012 | 99 | 0.110 |
Why?
| | Bacterial Vaccines | 1 | 2012 | 65 | 0.110 |
Why?
| | Antigen-Presenting Cells | 1 | 2012 | 170 | 0.110 |
Why?
| | Cell Line | 2 | 2016 | 3016 | 0.110 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 400 | 0.110 |
Why?
| | Mutagenesis | 1 | 2011 | 185 | 0.110 |
Why?
| | Chemokines | 1 | 2011 | 240 | 0.100 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 38 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2014 | 539 | 0.100 |
Why?
| | Killer Cells, Natural | 1 | 2012 | 386 | 0.100 |
Why?
| | Survival Analysis | 1 | 2013 | 1414 | 0.100 |
Why?
| | Immunization | 1 | 2012 | 403 | 0.100 |
Why?
| | Medication Adherence | 1 | 2014 | 557 | 0.100 |
Why?
| | Genetic Engineering | 1 | 2009 | 85 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2013 | 824 | 0.100 |
Why?
| | Plasmids | 1 | 2009 | 395 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 909 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1100 | 0.090 |
Why?
| | Mice, Knockout | 1 | 2013 | 2893 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2014 | 1227 | 0.080 |
Why?
| | Lung | 3 | 2013 | 3637 | 0.070 |
Why?
| | Cohort Studies | 3 | 2021 | 5011 | 0.070 |
Why?
| | Critical Care Outcomes | 1 | 2022 | 13 | 0.060 |
Why?
| | Coronavirus OC43, Human | 1 | 2021 | 4 | 0.060 |
Why?
| | Immunoglobulin Class Switching | 1 | 2021 | 18 | 0.060 |
Why?
| | Inflammation | 1 | 2013 | 2451 | 0.060 |
Why?
| | Renin-Angiotensin System | 1 | 2022 | 88 | 0.060 |
Why?
| | Receptors, Fc | 1 | 2021 | 43 | 0.060 |
Why?
| | Female | 7 | 2022 | 63035 | 0.060 |
Why?
| | Virus Internalization | 1 | 2021 | 49 | 0.060 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 78 | 0.050 |
Why?
| | Biomarkers | 2 | 2022 | 3501 | 0.050 |
Why?
| | Protein Domains | 1 | 2021 | 212 | 0.050 |
Why?
| | Models, Biological | 2 | 2021 | 1845 | 0.050 |
Why?
| | Jurkat Cells | 1 | 2019 | 145 | 0.050 |
Why?
| | Moths | 1 | 2019 | 35 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2828 | 0.050 |
Why?
| | Survivors | 1 | 2021 | 370 | 0.050 |
Why?
| | Respiration, Artificial | 1 | 2022 | 566 | 0.040 |
Why?
| | Proteome | 1 | 2021 | 334 | 0.040 |
Why?
| | Aged | 3 | 2022 | 20109 | 0.040 |
Why?
| | Zebrafish | 1 | 2019 | 410 | 0.040 |
Why?
| | Proteomics | 1 | 2021 | 772 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2015 | 51 | 0.040 |
Why?
| | Shigella | 1 | 2014 | 2 | 0.040 |
Why?
| | Focal Adhesions | 1 | 2014 | 45 | 0.030 |
Why?
| | Protein Array Analysis | 1 | 2014 | 64 | 0.030 |
Why?
| | Intracellular Space | 1 | 2014 | 81 | 0.030 |
Why?
| | Middle Aged | 3 | 2022 | 28753 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2014 | 105 | 0.030 |
Why?
| | Tetrahydrofolates | 1 | 2013 | 11 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2014 | 214 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 881 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2489 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2014 | 226 | 0.030 |
Why?
| | Adult | 3 | 2022 | 31979 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2019 | 763 | 0.030 |
Why?
| | Granzymes | 1 | 2012 | 40 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 3544 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2012 | 75 | 0.030 |
Why?
| | Gene Deletion | 1 | 2013 | 390 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2014 | 666 | 0.030 |
Why?
| | Leukocytes | 1 | 2012 | 301 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2014 | 546 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2229 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2021 | 6796 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 3118 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1517 | 0.020 |
Why?
| | Male | 3 | 2022 | 60993 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2012 | 804 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1188 | 0.020 |
Why?
| | Monocytes | 1 | 2012 | 517 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2009 | 177 | 0.020 |
Why?
| | Peptides | 1 | 2014 | 884 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 3447 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1032 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2012 | 489 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1184 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10971 | 0.020 |
Why?
| | Vaccination | 1 | 2012 | 962 | 0.020 |
Why?
| | Quality of Life | 1 | 2014 | 2136 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3910 | 0.020 |
Why?
| | Adolescent | 1 | 2021 | 18736 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2014 | 4625 | 0.020 |
Why?
|
|
Russo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|